Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_assertion description "[Its aberrant upregulation in the SCLC samples, both cell lines and primary tumors, which might have been caused by a yet unidentified mutations or by deletions of other gene, and its homology to alpha 4, which is thought to play a role in metastasis, suggest that altered alpha RLC expression may contribute to the acquisition of malignant phenotypes of this type of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_assertion evidence source_evidence_literature NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_assertion SIO_000772 8290272 NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_assertion wasDerivedFrom befree-2016 NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_assertion wasGeneratedBy ECO_0000203 NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1337801.RA110u-5_eu-5f9xSrL7SrZkcR7_3RuxL49D71yMWrcRE130_provenance.